Keros Therapeutics, Inc. Contracts & Agreements
43 Contracts & Agreements
- Business Finance (8 contracts)
- Business Operations (1)
- Human Resources (17)
- Intellectual Property (3)
- Real Estate (3)
- Uncategorized (11)
- Amendment No (Filed With SEC on February 28, 2024)
- Description of the Registrants Securities (Filed With SEC on February 28, 2024)
- Underwriting Agreement, dated January (Filed With SEC on January 4, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 4, 2023)
- First Amendment to Lease, by and between the Registrant and Revolution Labs Owner, LLC, dated January 6, 2023 (Filed With SEC on May 4, 2023)
- Amendment No. 2, dated as of March 11, 2022, and Amendment No. 3, dated as of December 11, 2022, to License Agreement by and between the registrant and Hansoh (Shanghai)... (Filed With SEC on March 3, 2023)
- Description of the Registrants Securities (Filed With SEC on March 3, 2023)
- Amendment to Offer Letter, dated August 1, 2022, between Jennifer Lachey and the Registrant (Filed With SEC on November 3, 2022)
- First Amendment to the Employment Agreement by and between the registrant and Keith Regnante, dated as of January 1, 2022 (Filed With SEC on March 9, 2022)
- Description of the Registrants Securities (Filed With SEC on March 9, 2022)
- License Agreement by and between the registrant and Hansoh (Shanghai) Healthtech Co., Ltd., dated as of December 12 (Filed With SEC on March 9, 2022)
- First Amendment to the Employment Agreement by and between the registrant and Jenn Lachey, dated as of January 1, 2022 (Filed With SEC on March 9, 2022)
- First Amendment to the Employment Agreement by and between the registrant and Simon Cooper, dated as of January 1, 2022 (Filed With SEC on March 9, 2022)
- Employment Agreement by and between Keros Therapeutics, Inc. and Christopher Rovaldi, dated as of January 28, 2022, effective as of February 1, 2022 (Filed With SEC on January 31, 2022)
- Indenture of Lease by and between the Registrant and Revolution Labs Owner, LLC, dated September 7, 2021 (Filed With SEC on November 4, 2021)
- Third Amendment to Lease Agreement by and between Keros Therapeutics, Inc. and 99 Hayden LLC, dated August 4, 2021 (Filed With SEC on August 5, 2021)
- Employment Agreement by and between Keros Therapeutics, Inc. and Simon Cooper, dated as of July 30, 2021 effective as of August 2, 2021 (Filed With SEC on August 2, 2021)
- Separation and Release Agreement by and between Keros Therapeutics, Inc. and Claudia Ordonez, dated and effective as of July 30, 2021 (Filed With SEC on August 2, 2021)
- Description of (Filed With SEC on March 25, 2021)
- Form of Underwriting Agreement (Filed With SEC on November 10, 2020)
- Employment Agreement by and between the registrant and Keith Regnante, dated as of March 31, 2020, to be effective upon the closing of this offering (Filed With SEC on April 1, 2020)
- Employment Agreement by and between the registrant and Claudia Ordonez, dated as of March 31, 2020, to be effective upon the closing of this offering (Filed With SEC on April 1, 2020)
- Employment Agreement by and between the registrant and Jenn Lachey, dated as of March 31, 2020, to be effective upon the closing of this offering (Filed With SEC on April 1, 2020)
- Employment Agreement by and between the registrant and Jasbir Seehra, dated as of March 31, 2020, to be effective upon the closing of this offering (Filed With SEC on April 1, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on April 1, 2020)
- Forms of Stock Option Grant Notice, Option Agreement, Notice of Exercise, Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement for the 2020 Equity... (Filed With SEC on April 1, 2020)
- 2020 Equity Incentive Plan (Filed With SEC on April 1, 2020)
- Form of Indemnity Agreement between the registrant and its directors and officers (Filed With SEC on April 1, 2020)
- Form of Common Stock Certificate (Filed With SEC on April 1, 2020)
- Form of Underwriting Agreement (Filed With SEC on April 1, 2020)
- Offer Letter Agreement by and between the registrant and Keith Regnante, dated as of February 7, 2020 (Filed With SEC on March 16, 2020)
- 2017 Stock Incentive Plan, as amended (Filed With SEC on March 16, 2020)
- Form of Stock Option Grant Notice and Option Agreement for the 2017 Stock Incentive Plan, as amended (Filed With SEC on March 16, 2020)
- 2020 Equity Incentive Plan (Filed With SEC on March 16, 2020)
- Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise for the 2020 Equity Incentive Plan (Filed With SEC on March 16, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on March 16, 2020)
- Offer Letter Agreement by and between the registrant and Jasbir Seehra, dated as of December 14, 2015 (Filed With SEC on March 16, 2020)
- Offer Letter Agreement by and between the registrant and Jenn Lachey, dated as of April 20, 2016 (Filed With SEC on March 16, 2020)
- Offer Letter Agreement by and between the registrant and Claudia Ordonez, dated as of August 20, 2019 (Filed With SEC on March 16, 2020)
- Exclusive Patent License Agreement by and between the registrant and The General Hospital Corporation, d/b/a Massachusetts General Hospital, or MGH, dated as of April 5, 2016, as... (Filed With SEC on March 16, 2020)
- Research Collaboration and Exclusive License Agreement by and between the registrant and Novo Nordisk A/S, dated as of December 14, 2017 (Filed With SEC on March 16, 2020)
- Amended and Restated Investors Rights Agreement by and among the registrant and certain of its stockholders, dated as of March 2, 2020 (Filed With SEC on March 16, 2020)
- Lease Agreement by and between the registrant and 128 Spring Street Lexington, LLC, dated March 20, 2017, as amended by the First Amendment to Lease Agreement by and between the... (Filed With SEC on March 16, 2020)